Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lewis

Showing results (1221-1230 of 1,275) with videos related to

Pageof 128
Sort By:
European Journal of Heart Failure|February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trialClara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
American Heart Journal|May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and designGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
Circulation. Heart Failure|March 21, 2025
Multiregional Implementation Initiative's Impact on Guideline-Based Performance Measures for Patients Hospitalized With Heart Failure: IMPLEMENT-HFAndrew J Sauer, Chandler Beon, Sruthi Cherkur, et al.
European Journal of Heart Failure|October 30, 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trialYogesh N V Reddy, Javed Butler, Kevin J Anstrom, et al.
JACC. Heart Failure|November 17, 2020
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
Cell Reports|July 5, 2016
Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin ResistanceXavier S Revelo, Magar Ghazarian, Melissa Hui Yen Chng, et al.
The New England Journal of Medicine|April 11, 2014
Spironolactone for heart failure with preserved ejection fractionBertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
European Journal of Heart Failure|October 5, 2020
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
Journal of Hepatology|June 18, 2016
Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunctionTim van Zutphen, Jolita Ciapaite, Vincent W Bloks, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 28, 2007
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trialE A DeFranco, J M O'Brien, C D Adair, et al.
Pageof 128

Showing results (1221-1230 of 1,275) with videos related to

Sort By:
Pageof 128
European Journal of Heart Failure|February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trialClara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
American Heart Journal|May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and designGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
Circulation. Heart Failure|March 21, 2025
Multiregional Implementation Initiative's Impact on Guideline-Based Performance Measures for Patients Hospitalized With Heart Failure: IMPLEMENT-HFAndrew J Sauer, Chandler Beon, Sruthi Cherkur, et al.
European Journal of Heart Failure|October 30, 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trialYogesh N V Reddy, Javed Butler, Kevin J Anstrom, et al.
JACC. Heart Failure|November 17, 2020
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
Cell Reports|July 5, 2016
Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin ResistanceXavier S Revelo, Magar Ghazarian, Melissa Hui Yen Chng, et al.
The New England Journal of Medicine|April 11, 2014
Spironolactone for heart failure with preserved ejection fractionBertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
European Journal of Heart Failure|October 5, 2020
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
Journal of Hepatology|June 18, 2016
Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunctionTim van Zutphen, Jolita Ciapaite, Vincent W Bloks, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 28, 2007
Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trialE A DeFranco, J M O'Brien, C D Adair, et al.
Pageof 128